Combihale (Ipratropium Bromide and Salbutamol) is indicated for the treatment of bronchospasm (airway narrowing) in patients with asthma and chronic obstructive pulmonary disease (COPD) for rapid relief of symptoms, as COMBIHALE provides dual action therapy offering a synergistic response.